Cephalosporins having (.alpha.-etherified oximino) acylamido gro

Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen in the nitrogen containing substituent

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424246, C07D50146

Patent

active

040791785

ABSTRACT:
The invention provides novel antibiotic compounds which are 7.beta.-acylamidoceph-3-em-4-carboxylic acids, and non-toxic derivatives thereof characterized in that the acylamido group has the structure ##STR1## WHERE R is a hydrogen atom or an organic group and R.sup.a is an etherifying monovalent organic group linked to the oxygen atom through a carbon atom. The compounds are syn isomers or exist as mixtures containing at least 75% of the syn isomer. These antibiotic compounds possess high antibacterial activity against a range or gram positive and gram negative organisms coupled with particularly high stability to .beta.-lactamases produced by various gram negative organisms. The invention is also concerned with the administration of the compounds.

REFERENCES:
Gregson et al., Abstract of L, "Chemical Abstracts", vol. 77, p. 405, abst. no. 126,662a.
Cook et al., Abstract of M, "Chemical Abstracts", vol. 78, p. 525, abst. no. 58,444z.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cephalosporins having (.alpha.-etherified oximino) acylamido gro does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cephalosporins having (.alpha.-etherified oximino) acylamido gro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cephalosporins having (.alpha.-etherified oximino) acylamido gro will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2231179

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.